As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss (2024)

Table of Contents
Journals Podcasts Citation References

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue

JAMA

    Sign In

    Individual Sign In

    Sign inCreate an Account

    Access through your institution

    Sign In

    Purchase Options:

    Buy this article

    Subscribe to the JAMA journal

    This Issue

    Views 80,064

    Comments 1

    Medical News & Perspectives

    April 26, 2023

    MelissaSuran,PhD, MSJ

    Article Information

    JAMA. 2023;329(19):1627-1629. doi:10.1001/jama.2023.2438

    visual abstract icon Visual Abstract editorial comment icon Editorial Comment related articles icon Related Articles author interview icon Interviews multimedia icon Multimedia audio icon Listen to this article
    • Review Long-Term Drug Treatment for Obesity

      Susan Z.Yanovski,MD; Jack A.Yanovski,MD, PhD

      JAMA

    • Original Investigation Effect of Subcutaneous Semaglutide on Body Weight in Adults With Obesity

      Thomas A.Wadden,PhD; Timothy S.Bailey,MD; Liana K.Billings,MD, MMSc; MelanieDavies,MD; Juan P.Frias,MD; AnnaKoroleva,MD; IldikoLingvay,MD, MPH, MSCS; Patrick M.O’Neil,PhD; Domenica M.Rubino,MD; DortheSkovgaard,MD, PhD; Signe O. R.Wallenstein,MSc; W. TimothyGarvey,MD; STEP 3 Investigators

      JAMA

    • Original Investigation Effect of Weekly Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

      DomenicaRubino,MD; NiclasAbrahamsson,MD; MelanieDavies,MD; DanHesse,PhD; Frank L.Greenway,MD; CamillaJensen,MSc; IldikoLingvay,MD, MPH, MSCS; OfriMosenzon,MD; JulioRosenstock,MD; Miguel A.Rubio,MD; GottfriedRudofsky,MD; SayehTadayon,MD; Thomas A.Wadden,PhD; DrorDicker,MD; STEP 4 Investigators; MetteFriberg; AndersSjödin; DrorDicker; GabriellaSegal; OfriMosenzon; MuhammadSabbah; YaelSofer; VictorVishlitzky; Eelco W.Meesters; MirelleSerlie; Ariannevan Bon; HelenaCardoso; PaulaFreitas; PedroCarneiro de Melo; MargaridaMonteiro; MarianaMonteiro; DírceaRodrigues; AyshaBadat; PankajJoshi; GulamLatiff; Essack A.Mitha; Hans H.Snyman; Elanevan Nieuwenhuizen; OlgaGonzález Albarrán; AssumptaCaixas; Carmende al Cuesta; Pedro PabloGarcia Luna; CristobalMorales Portillo; PedroMezquita Raya; Miguel AngelRubio; NiclasAbrahamsson; JohanHoffstedt; Fredrikvon Wowern; ErikUddman; BirgitBach-Kliegel; FelixBeuschlein; StefanBilz; AlainGolay; GottfriedRudofsky; ChristopherStrey; GalynaFadieienko; NataliiaKosei; TetianaTatarchuk; ValentynaVelychko; OlesyaZinych; Stephen L.Aronoff; Harold E.Bays; Andrew P.Brockmyre; Robert S.Call; CharlesCrump; Cyrus V.Desouza; ValerieEspinosa; Almena L.Free; Winston H.Gandy; Steven A.Geller; Gregory M.Gottschlich; Frank L.Greenway; LaurieHan-Conrad; WayneHarper; LeeHerman; MitzieHewitt; PriscillaHollander; Steven R.Kaster; AnastasiosManessis; Frederick A.Martin; Robert E.McNeill; Alexander V.Murray; Paul C.Norwood; John C.H.Reed; JulioRosenstock; Domenica M.Rubino; Martin J.Schear; Mark L.Warren

      JAMA

    • JenniferAbbasi

      JAMA

    • Clinical Trials Update Semaglutide’s Weight-Loss Benefits Were Sustained in a 2-Year Study

      AnitaSlomski

      JAMA

    • Original Investigation Effect of Weekly Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes

      Domenica M.Rubino,MD; Frank L.Greenway,MD; UsmanKhalid,MD, PhD; Patrick M.O’Neil,PhD; JulioRosenstock,MD; RasmusSørrig,MD, PhD; Thomas A.Wadden,PhD; AlicjaWizert,PhD; W. TimothyGarvey,MD; STEP 8 Investigators; CarlosArauz-Pacheco; KevinCannon; H. JacksonDowney; DavidFitz-Patrick; JeffreyGeohas; GreggGerety; JohnGilbert; PriscillaHollander; EricKlein; KarenLaufer; PhilipO'Donnell; PaulRosenblit; PhillipToth

      JAMA

    • Medical News in Brief Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says

      EmilyHarris

      JAMA

    • JenniferAbbasi

      JAMA

    • Medical News in Brief Semaglutide Improves Heart Failure and Cardiovascular Disease

      EmilyHarris

      JAMA

    • Research Letter GLP-1 Agonists and Gastrointestinal Adverse Events

      MohitSodhi,MSc; RaminRezaeianzadeh,BSc; AbbasKezouh,PhD; MahyarEtminan,PharmD, MSc

      JAMA

    • KateRuder,MSJ

      JAMA

    • Original Investigation Weight Loss Outcomes and Semaglutide Treatment for Patients With Overweight or Obesity

      WissamGhusn,MD; AlanDe la Rosa,MD; DanielSacoto,MD; LizethCifuentes,MD; AlejandroCampos,MD; FauziFeris,MD; Maria DanielaHurtado,MD, PhD; AndresAcosta,MD, PhD

      JAMA Network Open

    Audio (16:31)

    April 2023 Medical News Summary

    1x

    0:00 / 0:00

    Full Text

    Although semaglutide may not ring a bell, the drug has been popping up in news headlines and social media feeds since last year. That’s because the branded version called Ozempic has surged in popularity—and notoriety—for its off-label use as a weight-loss medication.

    Here’s what to know about this in-demand drug.

    Full Text

    Add or change institution

    Comment

    1 Comment for this article

    EXPAND ALL

    May 1, 2023

    Overall Acceptance of Semaglutide

    Gauranga Dhar, MD | Private Practice

    No doubt semaglutide, a novel GLP-1 agonist, is associated with a number of favorable effects including cardiorenal benefits. But its use also should be cautious.

    Since it is used to manage type 2 diabetes and obesity, theoretically semaglutide should be used lifelong.

    I am a practicing physician who took the drug and could not continue it more than a few months maximum because of number of gastrointestinal adverse effects.

    Medullary thyroid carcinoma (MTC) is one of the adverse effects of semaglutide, and that's why before starting this molecule, a physician should think twice and take a detailed

    family history.

    CONFLICT OF INTEREST: None Reported

    READ MORE

    Read More About

    Clinical Pharmacy and Pharmacology Obesity Lifestyle Behaviors Diet

    Download PDF Full Text

    Cite This

    Citation

    Suran M. As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss. JAMA. 2023;329(19):1627–1629. doi:10.1001/jama.2023.2438

    Manage citations:

    Ris (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley

    © 2024

    Comment

    Add or change institution

    Artificial Intelligence ResourceCenter

    Others Also Liked

    Select Your Interests

    Customize your JAMA Network experience by selecting one or more topics from the list below.

    • Academic Medicine
    • Acid Base, Electrolytes, Fluids
    • Allergy and Clinical Immunology
    • American Indian or Alaska Natives
    • Anesthesiology
    • Anticoagulation
    • Art and Images in Psychiatry
    • Artificial Intelligence
    • Assisted Reproduction
    • Bleeding and Transfusion
    • Cardiology
    • Caring for the Critically Ill Patient
    • Challenges in Clinical Electrocardiography
    • Climate and Health
    • Climate Change
    • Clinical Challenge
    • Clinical Decision Support
    • Clinical Implications of Basic Neuroscience
    • Clinical Pharmacy and Pharmacology
    • Complementary and Alternative Medicine
    • Consensus Statements
    • Coronavirus (COVID-19)
    • Critical Care Medicine
    • Cultural Competency
    • Dental Medicine
    • Dermatology
    • Diabetes and Endocrinology
    • Diagnostic Test Interpretation
    • Drug Development
    • Electronic Health Records
    • Emergency Medicine
    • End of Life, Hospice, Palliative Care
    • Environmental Health
    • Equity, Diversity, and Inclusion
    • Ethics
    • Facial Plastic Surgery
    • Gastroenterology and Hepatology
    • Genetics and Genomics
    • Genomics and Precision Health
    • Geriatrics
    • Global Health
    • Guide to Statistics and Methods
    • Guidelines
    • Hair Disorders
    • Health Care Delivery Models
    • Health Care Economics, Insurance, Payment
    • Health Care Quality
    • Health Care Reform
    • Health Care Safety
    • Health Care Workforce
    • Health Disparities
    • Health Inequities
    • Health Policy
    • Health Systems Science
    • Hematology
    • History of Medicine
    • Humanities
    • Hypertension
    • Images in Neurology
    • Implementation Science
    • Infectious Diseases
    • Innovations in Health Care Delivery
    • JAMA Infographic
    • Law and Medicine
    • Leading Change
    • Less is More
    • LGBTQIA Medicine
    • Lifestyle Behaviors
    • Medical Coding
    • Medical Devices and Equipment
    • Medical Education
    • Medical Education and Training
    • Medical Journals and Publishing
    • Melanoma
    • Mobile Health and Telemedicine
    • Narrative Medicine
    • Nephrology
    • Neurology
    • Neuroscience and Psychiatry
    • Notable Notes
    • Nursing
    • Nutrition
    • Nutrition, Obesity, Exercise
    • Obesity
    • Obstetrics and Gynecology
    • Occupational Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otolaryngology
    • Pain Medicine
    • Palliative Care
    • Pathology and Laboratory Medicine
    • Patient Care
    • Patient Information
    • Pediatrics
    • Performance Improvement
    • Performance Measures
    • Perioperative Care and Consultation
    • Pharmacoeconomics
    • Pharmacoepidemiology
    • Pharmacogenetics
    • Pharmacy and Clinical Pharmacology
    • Physical Medicine and Rehabilitation
    • Physical Therapy
    • Physician Leadership
    • Poetry
    • Population Health
    • Primary Care
    • Professional Well-being
    • Professionalism
    • Psychiatry and Behavioral Health
    • Public Health
    • Pulmonary Medicine
    • Radiology
    • Regulatory Agencies
    • Reproductive Health
    • Research, Methods, Statistics
    • Resuscitation
    • Rheumatology
    • Risk Management
    • Scientific Discovery and the Future of Medicine
    • Shared Decision Making and Communication
    • Sleep Medicine
    • Sports Medicine
    • Stem Cell Transplantation
    • Substance Use and Addiction Medicine
    • Surgery
    • Surgical Innovation
    • Surgical Pearls
    • Teachable Moment
    • Technology and Finance
    • The Art of JAMA
    • The Arts and Medicine
    • The Rational Clinical Examination
    • Tobacco and e-Cigarettes
    • Toxicology
    • Translational Medicine
    • Trauma and Injury
    • Treatment Adherence
    • Ultrasonography
    • Urology
    • Users' Guide to the Medical Literature
    • Vaccination
    • Venous Thromboembolism
    • Veterans Health
    • Violence
    • Women's Health
    • Workflow and Process
    • Wound Care, Infection, Healing

    Save Preferences

    Privacy Policy | Terms of Use

    X

    .

    ×

    Access your subscriptions

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Get full journal access for 1 year

    Get unlimited access and a printable PDF ($40.00)—
    Sign in or create a free account

    Rent this article from DeepDyve

    Access your subscriptions

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Get full journal access for 1 year

    Get unlimited access and a printable PDF ($40.00)—
    Sign in or create a free account

    Rent this article from DeepDyve

    Sign in to access free PDF

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Save your search

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Customize your interests

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Create a personal account or sign in to:

    • Register for email alerts with links to free full-text articles
    • Access PDFs of free articles
    • Manage your interests
    • Save searches and receive search alerts

      Privacy Policy

      Make a comment

      Free access to newly published articles

      To register for email alerts, access free PDF, and more

      Create a personal account or sign in to:

      • Register for email alerts with links to free full-text articles
      • Access PDFs of free articles
      • Manage your interests
      • Save searches and receive search alerts

        Privacy Policy

        As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss (2024)

        References

        Top Articles
        Latest Posts
        Article information

        Author: Manual Maggio

        Last Updated:

        Views: 6010

        Rating: 4.9 / 5 (49 voted)

        Reviews: 80% of readers found this page helpful

        Author information

        Name: Manual Maggio

        Birthday: 1998-01-20

        Address: 359 Kelvin Stream, Lake Eldonview, MT 33517-1242

        Phone: +577037762465

        Job: Product Hospitality Supervisor

        Hobby: Gardening, Web surfing, Video gaming, Amateur radio, Flag Football, Reading, Table tennis

        Introduction: My name is Manual Maggio, I am a thankful, tender, adventurous, delightful, fantastic, proud, graceful person who loves writing and wants to share my knowledge and understanding with you.